Another promising treatment: an anti-CD20 antibody--kind of a second-generation Rituxan--that Genentech plans to test against rheumatoid arthritis, lupus and multiple sclerosis.

FORBES: Magazine Article

In the next decade, Genzel hopes the planned next generation of 30 meter-class telescopes will enable black hole astronomers to test general relativity around the event horizon itself.

FORBES: Why Our Galaxy's Supermassive Black Hole Is Hardly The Source For A 2012 Doomsday 'Killshot'